Mar 5, 2026 09:01AM
Mar 5, 2026 09:00AM
Feb 25, 2026 04:00PM
Feb 24, 2026 09:15AM
Feb 2, 2026 08:00AM
Feb 2, 2026 08:00AM
Jan 12, 2026 08:10AM Arcutis projects ZORYVE sales of $455-470 million for 2026
Jan 12, 2026 08:00AM
Dec 21, 2025 08:00PM
Nov 17, 2025 08:04AM
Nov 17, 2025 08:00AM
Nov 13, 2025 08:00AM
Nov 13, 2025 08:00AM
Nov 4, 2025 08:04AM Arcutis publishes long-term ZORYVE safety data for seborrheic dermatitis
Nov 4, 2025 08:00AM
Oct 30, 2025 09:15AM
Oct 30, 2025 08:03AM
Oct 30, 2025 08:00AM
Oct 28, 2025 08:34AM
Oct 28, 2025 08:30AM
Oct 24, 2025 08:00AM Arcutis presents new ZORYVE data on sleep quality and long-term control
Oct 24, 2025 08:00AM
Oct 6, 2025 08:00AM
Oct 6, 2025 08:00AM
Sep 17, 2025 04:00AM
Sep 16, 2025 09:00AM
Sep 3, 2025 11:44AM
Sep 3, 2025 11:43AM Arcutis Submits Supplemental New Drug Application for ZORYVE® (roflumilast) Cream 0.3% to Expand Indication for Treatment of Plaque Psoriasis in Children Ages 2 to 5
Sep 3, 2025 07:30AM
Aug 6, 2025 04:00PM
Jul 31, 2025 07:00AM
Jun 26, 2025 08:00AM
Jun 10, 2025 08:00AM
Jun 6, 2025 08:00AM
Jun 3, 2025 06:55AM H.C. Wainwright Reiterates Buy Rating on Arcutis Biotherapeutics Inc. (ARQT)
May 22, 2025 02:16PM
May 22, 2025 02:12PM
May 7, 2025 11:19AM
May 7, 2025 11:18AM
May 6, 2025 04:00PM
Apr 17, 2025 08:00AM
Apr 10, 2025 04:31PM Arcutis Biotherapeutics (ARQT) appoints Latha Vairavan as CFO after Topper retirement
Apr 10, 2025 04:30PM
Apr 4, 2025 04:00PM
Apr 3, 2025 06:49AM
Apr 2, 2025 01:18PM
Apr 2, 2025 01:16PM
Apr 2, 2025 01:16PM
Mar 27, 2025 08:00AM Arcutis to Present at the 24th Annual Needham Virtual Healthcare Conference
Mar 7, 2025 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All